Evolving Standards in Clinical NGS (updated)
History of clinical NGS standards Advancements in Next-Generation Sequencing (NGS) have significantly reduced sequencing costs, making the
Press Release | Euformatics partners with Bioportugal to expand in the Portuguese market
Espoo, June 20th, 2024. Euformatics, a Finnish bioinformatics company that develops clinical genomic data analysis tools, announced that it has
Partnership of Euformatics, BC Platforms, Oncompass Medicine, and Genomate Health Selected to Develop Oncology NGS Reporting Solution for Seven Major European Hospitals
Espoo, Finland, 29th of May, 2024 - Euformatics, in partnership with Finland’s BC Platforms and Hungary’s Oncompass Medicine and Genomate
PRESS RELEASE | Universitas Gadjah Mada chooses Euformatic’s Genomics Hub to gain insight into somatic analysis
Espoo, Finland May 27th, 2024. Universitas Gadjah Mada, located in Central Java, Indonesia, has joined hands with Euformatics, a leading provider of
Press Release | Euformatics partners with Ouilab Group in France to power their clinical NGS data analysis
Espoo, Finland, May 15th, 2024. Euformatics, a world leader in NGS quality control and variant interpretation tools, announced that it has signed a
Case Study: Cohort Analysis in Clinical Genomics Research
Are you looking for a needle in a haystack? Then imagine looking for it without knowing what a needle looks like. The genome knowledge of today is
Roadmap to IVDR for Genomics Hub clinical NGS tools
Euformatics’ has recently achieved ISO 13485:2016 certification by demonstrating its commitment to quality and safety. It plays an important role